BostonGene Stock
HealthTechLooking to sell BostonGene stock or options?
Contact usFounded: 2015Funding to Date: $200M
Visit websiteBostonGene has created biomedical software that is specifically designed for sophisticated patient analysis and tailor-made therapy. Its solution executes analytics for each patient's unique genetics, tumor, and tumor microenvironment, as well as clinical characteristics and disease profile. This assists clinicians in assessing feasible treatment options.
Investors Include:
NEC (Japan), Japan Industrial Partners, Impact Investment Capital.
Looking to sell BostonGene Stock or Options?
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you
Loading